Legal & General Group’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38
Closed -$46 3458
2025
Q1
$46 Sell
38
-2,444
-98% -$3.43K ﹤0.01% 3375
2024
Q4
$3.2K Hold
2,482
﹤0.01% 3364
2024
Q3
$6.83K Hold
2,482
﹤0.01% 3339
2024
Q2
$5.6K Buy
+2,482
New +$7.54K ﹤0.01% 3370
2021
Q2
Sell
-4,552
Closed -$10K 3557
2021
Q1
$10K Hold
4,552
﹤0.01% 3376
2020
Q4
$10K Hold
4,552
﹤0.01% 3340
2020
Q3
$12K Sell
4,552
-1,988
-30% -$5.57K ﹤0.01% 3155
2020
Q2
$20K Sell
6,540
-338
-5% -$850 ﹤0.01% 3068
2020
Q1
$13K Sell
6,878
-2,388
-26% -$5.81K ﹤0.01% 3077
2019
Q4
$27K Buy
9,266
+1,600
+21% +$5.56K ﹤0.01% 3095
2019
Q3
$28K Buy
7,666
+2,305
+43% +$8.33K ﹤0.01% 2995
2019
Q2
$22K Buy
+5,361
New +$23.2K ﹤0.01% 3159

Other funds holding GALT